Insmed Inc [INSM] stock is trading at $73.85, up 0.63%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The INSM shares have gain 1.69% over the last week, with a monthly amount glided 11.40%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Insmed Inc [NASDAQ: INSM] stock has seen the most recent analyst activity on April 23, 2024, when Truist initiated its Buy rating and assigned the stock a price target of $48. Previously, Wolfe Research started tracking the stock with Outperform rating on February 15, 2024, and set its price target to $42. On December 08, 2023, Wells Fargo initiated with a Overweight rating and assigned a price target of $55 on the stock. Guggenheim initiated its recommendation with a Buy and recommended $50 as its price target on July 26, 2023. Mizuho started tracking with a Buy rating for this stock on December 09, 2022, and assigned it a price target of $28. In a note dated December 07, 2022, Barclays initiated an Overweight rating and provided a target price of $37 on this stock.
Insmed Inc [INSM] stock has fluctuated between $21.92 and $80.53 over the past year. Currently, Wall Street analysts expect the stock to reach $87.5 within the next 12 months. Insmed Inc [NASDAQ: INSM] shares were valued at $73.85 at the most recent close of the market. An investor can expect a potential return of 18.48% based on the average INSM price forecast.
Analyzing the INSM fundamentals
Insmed Inc [NASDAQ:INSM] reported sales of 342.96M for the trailing twelve months, which represents a growth of 18.15%. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at -2.14%, Pretax Profit Margin comes in at -2.51%, and Net Profit Margin reading is -2.52%. To continue investigating profitability, this company’s Return on Assets is posted at -0.42, Equity is 12.59 and Total Capital is -0.41. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 2.34.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 72.53 points at the first support level, and at 71.22 for the second support level. However, for the 1st resistance point, the stock is sitting at 75.16, and for the 2nd resistance point, it is at 76.48.
Ratios To Look Out For
For context, Insmed Inc’s Current Ratio is 6.37. As well, the Quick Ratio is 5.99, while the Cash Ratio is 1.78. Considering the valuation of this stock, the price to sales ratio is 38.52, the price to book ratio is 27.32.
Transactions by insiders
Recent insider trading involved Lewis William, Chair and CEO, that happened on Dec 12 ’24 when 18750.0 shares were sold. Chair and CEO, Lewis William completed a deal on Dec 12 ’24 to sell 6830.0 shares. Meanwhile, Officer Lewis William bought 25580.0 shares on Dec 12 ’24.
